Immune Checkpoint Inhibitors in Head and Neck Cancer: Understanding the Current Evidence and Future Directions

Download All

Download slidesets and review an archived webcast from a live symposium in which 3 experts discussed the rationale for checkpoint inhibition in advanced HNSCC, provided practical guidance on clinical use, and assessed promising near-future immunotherapies for HNSCC. Review key points for HNSCC treatment with a downloadable resource guide.

Barbara Burtness, MD
Program Director
Robert L. Ferris, MD, PhD
Cristina P. Rodriguez, MD

Downloadable Slidesets

Download these slides from a CCO symposium in Austin discussing the rationale for checkpoint inhibition in advanced HNSCC, practical guidance on clinical use, and promising near-future immunotherapies for HNSCC.

Barbara Burtness, MD
Program Director
Released: May 1, 2019

Download these slides from a CCO symposium in Austin discussing the rationale for checkpoint inhibition in advanced HNSCC, practical guidance on clinical use, and promising near-future immunotherapies for HNSCC.

Robert L. Ferris, MD, PhD Released: May 1, 2019

Download these slides from a CCO symposium in Austin discussing the rationale for checkpoint inhibition in advanced HNSCC, practical guidance on clinical use, and promising near-future immunotherapies for HNSCC.

Cristina P. Rodriguez, MD Released: May 1, 2019
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings